Blood pressure tablets recalled over potential cancer risk, FDA announces.
Four lots of the blood pressure medication Quinapril were voluntarily recalled last week by drug manufacturer Lupin Pharmaceuticals Inc. over concerns it could increase the risk of cancer, Lupin Pharmaceuticals Inc.’s Quinapril tablets, sold in 20 mg and 40 mg, may contain an elevated level of nitrosamine impurity, N-Nitroso-Quinapril, above the acceptable daily intake level.
“Everyone is exposed to some level of nitrosamines,” the recall states. “ These impurities may increase the risk of cancer if people are exposed to them above acceptable levels over long periods of time.”Lupin is recalling its 20 mg Quinapril tablets sold in 90 count bottles. Patients who are on the medication don’t need to stop taking it immediately, but are advised to discuss an alternative treatment with their healthcare provider.
The affected lots were distributed from March 2021 to Sept. 2022 and have expiry dates ranging from Dec. 2022 to March 2024. They came in 90-count bottles. See the Lupin Pharmaceuticals Inc. said it stopped making the drug in September, and was working with distributors to arrange for the return of the recalled product lots.Chevrolet Bolt among cars recalled:Quinapril is used to treat high blood pressure. Another drug maker
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Blood pressure tablets recalled over potential cancer risk, FDA announcesFour lots of the blood pressure medication Quinapril were voluntarily recalled over concerns it could increase the risk of cancer, the Food and Drug Administration said.
Read more »
FDA Fast-Tracks Overdose Drug Naloxone for Use Without PrescriptionA pharmaceutical nonprofit was granted priority review from the FDA to make an inexpensive overdose-reversal drug for use without a prescription
Read more »
WSJ News Exclusive | FDA, Concerned About Safety, Explores Regulating CBD in Foods, SupplementsThe agency is studying whether cannabis-derived ingredients are safe in food and supplements and aims to reveal its oversight plans in the coming months.
Read more »
U.S. FDA weighs regulating cannabis compound CBD in food, supplements - WSJAfter weighing the evidence on the compound's safety, the FDA will decide within months how to regulate legal cannabis and whether that will require new agency rules or new legislation from Congress, according to the report. Cannabis products, excluding Jazz Pharmaceuticals PLC's Epidiolex, are illegal at the federal level in the United States, although some states allow their use. The agency wants to know if CBD can be safely eaten every day for a long period or during pregnancy amid concerns about future fertility, Patrick Cournoyer, who heads the FDA office developing the agency's cannabis strategy, told WSJ.
Read more »
Did Keanu Reeves Say Hollywood Elites Use the ‘Blood of Babies’ to Get High?Reports that the actor stated Hollywood elites engage in the ritual abuse of children and the practice of drinking their blood are fake news.
Read more »
![‘The Witcher: Blood Origin’ Creators Explain the First Witcher [Exclusive]](https://i.headtopics.com/images/2022/12/27/collider/the-witcher-blood-origin-creators-explain-the-firs-the-witcher-blood-origin-creators-explain-the-firs-1607773841563983875.webp?w=640)
‘The Witcher: Blood Origin’ Creators Explain the First Witcher [Exclusive]TheWitcherBloodOrigin creators explain the origin of the first Witcher and how the spinoff connects to the main series.
Read more »